Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

by

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

Leave A Comment

Your email address will not be published. Required fields are marked *